Americans overspend $73bn on branded drugs

File this under ‘unintended consequences.’ A number of health care organizations are complaining that a final guideline the US Food and Drug Administration recently released for naming both biologic medicines… The post Americans overspend $73bn on branded drugs appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.

Biotechblog